A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or prison.
Service Response and Content Removal
According to the social media company, the service has removed violative content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in enhancing compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.
Within moments of entering one community, a seller posted contact information, where the majority of purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Details and Costs
Inside these groups, messages show black plastic packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service stated it actively monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly significant health risks”.
